AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
23 Apr 2009 04:48 PM
RNS
IRESSA CHMP positive opinion
23 Apr 2009 01:00 PM
RNS
FDA extend timeline for Ongly
17 Apr 2009 07:00 AM
RNS
Pulmicort Respules TRO Apotex
09 Apr 2009 07:00 AM
RNS
Seroquel XR MDD and GAD Adcom
07 Apr 2009 07:00 AM
RNS
Pulmicort Apotex litigation
06 Apr 2009 07:00 AM
RNS
OTC divestment approval
06 Apr 2009 07:00 AM
RNS
Symbicort CRL
03 Apr 2009 06:10 PM
RNS
FDA AdCom materials posted
02 Apr 2009 03:00 PM
RNS
Director/PDMR Shareholding
02 Apr 2009 07:00 AM
RNS
Onglyza AdComm
01 Apr 2009 04:30 PM
RNS
Director/PDMR Shareholding
31 Mar 2009 04:30 PM
RNS
Total Voting Rights
30 Mar 2009 05:30 PM
RNS
Director/PDMR Shareholding
30 Mar 2009 05:30 PM
RNS
Director/PDMR Shareholding
30 Mar 2009 05:30 PM
RNS
Director/PDMR Shareholding
30 Mar 2009 05:30 PM
RNS
Director/PDMR Shareholding
25 Mar 2009 04:30 PM
RNS
Director/PDMR Shareholding
25 Mar 2009 04:30 PM
RNS
Director/PDMR Shareholding
20 Mar 2009 04:30 PM
RNS
Annual Information Update
17 Mar 2009 06:02 PM
RNS
Filing of 20-F
04 Mar 2009 03:03 PM
RNS
Annual Report and Accounts
02 Mar 2009 07:00 AM
RNS
Symbicort COPD
27 Feb 2009 04:00 PM
RNS
Total Voting Rights
27 Feb 2009 10:00 AM
RNS
Board change
27 Feb 2009 07:00 AM
RNS
Seroquel XR CRL for GAD
26 Feb 2009 04:30 PM
RNS
Director/PDMR Shareholding
26 Feb 2009 04:30 PM
RNS
Director/PDMR Shareholding
26 Feb 2009 04:30 PM
RNS
Director/PDMR Shareholding
25 Feb 2009 04:30 PM
RNS
Director/PDMR Shareholding
25 Feb 2009 04:30 PM
RNS
Director/PDMR Shareholding
25 Feb 2009 01:00 PM
RNS
Seroquel XR
24 Feb 2009 07:00 AM
RNS
AstraZeneca and MAP: UDB
30 Jan 2009 04:00 PM
RNS
Total Voting Rights
29 Jan 2009 11:00 AM
RNS
Final Results - part 3 of 3
29 Jan 2009 11:00 AM
RNS
Final Results - part 2 of 3
29 Jan 2009 11:00 AM
RNS
AstraZeneca and Pozen : PN400
29 Jan 2009 11:00 AM
RNS
Currency Sensitivity Guide
29 Jan 2009 11:00 AM
RNS
Final Results - part 1 of 3
28 Jan 2009 09:00 AM
RNS
Notice of Results
22 Jan 2009 12:00 PM
RNS
Director/PDMR Shareholding
06 Jan 2009 08:00 AM
PRN
MedImmune Submits Marketing Authorisation Appli...
05 Jan 2009 04:00 PM
RNS
Total Voting Rights
24 Dec 2008 07:00 AM
RNS
Seroquel XR CRL
19 Dec 2008 12:38 PM
RNS
AstraZeneca and Map Pharmaceu
12 Dec 2008 07:00 AM
RNS
FDA AdCom on Symbicort
11 Dec 2008 11:00 AM
RNS
Return of Rights to Infinity
09 Dec 2008 07:00 AM
RNS
Topline phase IIb results for
08 Dec 2008 12:30 PM
RNS
AstraZeneca and BMS - Dapagli
03 Dec 2008 01:00 PM
RNS
PN 400 Phase III Studies
28 Nov 2008 04:00 PM
RNS
Total Voting Rights

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100